NIAGEN BIOSCIENCE, INC. Accounts Receivable, Allowance for Credit Loss
NIAGEN BIOSCIENCE, INC. (NAGE) had Accounts Receivable, Allowance for Credit Loss of $285.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-08-04
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss $285.00K.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss $277.00K.
- 2020-12-31: Accounts Receivable, Allowance for Credit Loss $0.00.
- 2019-12-31: Accounts Receivable, Allowance for Credit Loss $2.73M; Accounts Receivable, Allowance for Credit Loss as first filed $2.76M.
| Period end | Accounts Receivable, Allowance for Credit Loss | Accounts Receivable, Allowance for Credit Loss as first filed |
|---|---|---|
| 2026-06-30 | $285.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $277.00K 10-Q · filed 2026-05-06 | |
| 2020-12-31 | $0.00 10-K · filed 2021-03-12 | |
| 2019-12-31 | $2.73M 10-K · filed 2021-03-12 | $2.76M 10-K · filed 2020-03-10 |
| 2018-12-31 | $537.00K 10-K · filed 2020-03-10 | |
| 2017-12-30 | $669.00K 10-K · filed 2019-03-07 | |
| 2016-12-31 | $1.08M 10-K · filed 2018-03-15 | |
| 2016-01-02 | $367.00K 10-K · filed 2017-03-16 | |
| 2013-09-28 | $10.00K 10-Q · filed 2013-11-21 | |
| 2013-06-29 | $17.00K 10-Q/A · filed 2013-12-05 | |
| 2013-03-30 | $18.00K 10-Q/A · filed 2013-12-05 | |
| 2012-12-29 | $433.00K 10-K · filed 2014-03-27 | $450.00K 10-K · filed 2013-03-29 |
| 2012-09-29 | $920.00K 10-Q · filed 2012-11-08 | |
| 2011-12-31 | $9.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |